IL1B and systemic sclerosis: In contrast with the study by Hussein et al., in which a distinct elevation of serum IL1β was observed in SSc patients when compared to controls [133], in a more recent work no significant difference in serum concentrations of IL1β and IL1α was observed between SSc patients and healthy individuals, even if SSc subjects with high IL1α were more likely to have DUs [134].